Form 4: Quest Diagnostics Director Reports Phantom Stock Units
Statement of Changes in Beneficial Ownership
Quest Diagnostics Director Timothy C. Wentworth reports acquisition of phantom stock units under a deferred compensation plan.
Summary
- Timothy C. Wentworth, a Director at Quest Diagnostics Inc., has reported the acquisition of 144 phantom stock units.
- These units were acquired on July 1, 2026, as a result of elective deferrals of his director's cash compensation.
- The phantom stock units are part of the Quest Diagnostics Incorporated Amended and Restated Deferred Compensation Plan for Directors.
- These units will become payable in cash upon Mr. Wentworth's termination of service as a director.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral filing, as it represents a standard reporting of director compensation and does not indicate significant new financial performance or strategic shifts.
Positives
- Director compensation plan is active and being utilized.
- The company has a formal plan for deferred compensation for its directors.
Risks
- The value of the phantom stock units is tied to the company's stock performance, which can be volatile.
- Payment of the phantom stock units is contingent on the reporting person's termination of service as a director.
Future Outlook
The phantom stock units will be settled in cash upon the reporting person's termination of service as a director.
Industry Context
StockSavvy.ai notes that this filing is a routine Form 4, indicating a non-open market transaction by an insider, specifically a director. Such filings are common for reporting compensation-related equity awards or deferrals.
Related Party Transactions
- Acquisition of phantom stock units by Director Timothy C. Wentworth as part of his compensation.
Stakeholder Impact
- Shareholders: No immediate impact, as this is a compensation-related transaction and not an open market trade. It reflects the company's compensation structure for directors.
- Employees: No direct impact.
- Management: Standard reporting for director compensation.
- Creditors: No direct impact.
Next Steps
- Payment of phantom stock units in cash upon termination of director service.
Key Dates
| Date | Description |
|---|---|
| 07/01/2026 | Date of earliest transaction and acquisition of phantom stock units. |
| 07/02/2026 | Date of signature for the filing. |
Keywords
Quest Diagnostics, DGX, Form 4, Insider Trading, Director Compensation, Phantom Stock Units, Deferred Compensation, SEC Filing
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.